Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
Xiaohong R. Yang(Cancer Genetics (United States)), Dallas R. English, Angela Cox, Marjanka K. Schmidt(University of Cambridge), Sebastian Weihbrecht, Laura van ‘t Veer, Ellen L. Goode(Mayo Clinic in Arizona), Laura Baglietto, Fergus J. Couch(Mayo Clinic), Peter A. Fasching(Universitätsklinikum Erlangen), Keith Humphreys(Stanford Medicine), Jenny Chang‐Claude(Universität Hamburg), Beata Pepłońska, Jonine D. Figueroa, Annegien Broeks, Flora E. van Leeuwen(The Netherlands Cancer Institute), Päivi Heikkilä(University of Helsinki), Kamila Czene(Karolinska Institutet), Roger L. Milne(The University of Melbourne), Esther M. John, Irene L. Andrulis(University of Toronto), Anna Marie Mulligan, Per Hall(Karolinska Institutet), Nayana Weerasooriya, Judith Heinz, Heli Nevanlinna(University of Helsinki), Carl Blomqvist(University of Helsinki), Alina Vrieling(Radboud University Nijmegen), Louise A. Brinton(National Cancer Institute), Dieter Flesch‐Janys, Fiona M. Blows(University of Cambridge), Christian R. Loehberg, Tuomas Heikkinen(University of Helsinki), Sebastian M. Jud, Julia A. Knight, Stephen J. Chanock(National Cancer Institute), Jianjun Liu(University of Kentucky), Amanda B. Spurdle(QIMR Berghofer Medical Research Institute), Matthias W. Beckmann, Mia M. Gaudet, Kristiina Aittomäki(University of Helsinki), Hatef Darabi, Gord Glendon, Rebecca Hein(Technical University of Munich), David L. Wachter, Arndt Hartmann, Frances P. O’Malley(Lunenfeld-Tanenbaum Research Institute), Jolanta Lissowska, Kristy Driver(University of Cambridge), Hans‐Peter Sinn(Heidelberg University)
Cited by 716
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k